Question 1

Do analysts rate ARCC or CCAP?

Accepted Answer

Ares Capital currently has a consensus price target of $20.40, indicating a potential upside of 2.41%. Crescent Capital BDC has a consensus price target of $13.10, indicating a potential upside of 22.32%. Given Crescent Capital BDC's higher possible upside, analysts clearly believe Crescent Capital BDC is more favorable than Ares Capital. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ares Capital 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.73 Crescent Capital BDC 0 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.17

Question 2

Is ARCC or CCAP a better dividend stock?

Accepted Answer

Ares Capital pays an annual dividend of $1.92 per share and has a dividend yield of 9.6%. Crescent Capital BDC pays an annual dividend of $1.36 per share and has a dividend yield of 12.7%. Ares Capital pays out 142.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC pays out -1,511.1% of its earnings in the form of a dividend. Crescent Capital BDC has raised its dividend for 1 consecutive years. Crescent Capital BDC is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Question 3

Which has higher earnings & valuation, ARCC or CCAP?

Accepted Answer

Ares Capital has higher revenue and earnings than Crescent Capital BDC. Crescent Capital BDC is trading at a lower price-to-earnings ratio than Ares Capital, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ares Capital $3.05B 4.69 $1.30B $1.35 14.76 Crescent Capital BDC $167.29M 2.36 $34.51M -$0.09 N/A

Question 4

Do insiders & institutionals have more ownership in ARCC or CCAP?

Accepted Answer

27.4% of Ares Capital shares are held by institutional investors. Comparatively, 49.5% of Crescent Capital BDC shares are held by institutional investors. 0.5% of Ares Capital shares are held by insiders. Comparatively, 1.2% of Crescent Capital BDC shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Question 5

Is ARCC or CCAP more profitable?

Accepted Answer

Ares Capital has a net margin of 30.91% compared to Crescent Capital BDC's net margin of -2.02%. Ares Capital's return on equity of 9.80% beat Crescent Capital BDC's return on equity. Company Net Margins Return on Equity Return on Assets Ares Capital 30.91% 9.80% 4.50% Crescent Capital BDC -2.02% 9.02% 3.82%

Question 6

Which has more risk and volatility, ARCC or CCAP?

Accepted Answer

Ares Capital has a beta of 0.56, suggesting that its share price is 44% less volatile than the broader market. Comparatively, Crescent Capital BDC has a beta of 0.52, suggesting that its share price is 48% less volatile than the broader market.

Question 7

Does the media prefer ARCC or CCAP?

Accepted Answer

In the previous week, Ares Capital had 9 more articles in the media than Crescent Capital BDC. MarketBeat recorded 19 mentions for Ares Capital and 10 mentions for Crescent Capital BDC. Crescent Capital BDC's average media sentiment score of 1.18 beat Ares Capital's score of 0.96 indicating that Crescent Capital BDC is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ares Capital 10 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive Crescent Capital BDC 5 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Question 8

Do analysts rate CCAP or CGBD?

Accepted Answer

Crescent Capital BDC currently has a consensus target price of $13.10, indicating a potential upside of 22.32%. Carlyle Secured Lending has a consensus target price of $12.50, indicating a potential upside of 10.13%. Given Crescent Capital BDC's higher possible upside, research analysts plainly believe Crescent Capital BDC is more favorable than Carlyle Secured Lending. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Crescent Capital BDC 0 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.17 Carlyle Secured Lending 0 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.43

Question 9

Is CCAP or CGBD a better dividend stock?

Accepted Answer

Crescent Capital BDC pays an annual dividend of $1.36 per share and has a dividend yield of 12.7%. Carlyle Secured Lending pays an annual dividend of $1.40 per share and has a dividend yield of 12.3%. Crescent Capital BDC pays out -1,511.1% of its earnings in the form of a dividend. Carlyle Secured Lending pays out 274.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has raised its dividend for 1 consecutive years. Crescent Capital BDC is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Question 10

Which has better earnings & valuation, CCAP or CGBD?

Accepted Answer

Carlyle Secured Lending has higher revenue and earnings than Crescent Capital BDC. Crescent Capital BDC is trading at a lower price-to-earnings ratio than Carlyle Secured Lending, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Crescent Capital BDC $167.29M 2.36 $34.51M -$0.09 N/A Carlyle Secured Lending $255.57M 3.06 $69.97M $0.51 22.25

Question 11

Do insiders and institutionals have more ownership in CCAP or CGBD?

Accepted Answer

49.5% of Crescent Capital BDC shares are held by institutional investors. Comparatively, 24.5% of Carlyle Secured Lending shares are held by institutional investors. 1.2% of Crescent Capital BDC shares are held by company insiders. Comparatively, 0.4% of Carlyle Secured Lending shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Question 12

Is CCAP or CGBD more profitable?

Accepted Answer

Carlyle Secured Lending has a net margin of 14.26% compared to Crescent Capital BDC's net margin of -2.02%. Crescent Capital BDC's return on equity of 9.02% beat Carlyle Secured Lending's return on equity. Company Net Margins Return on Equity Return on Assets Crescent Capital BDC -2.02% 9.02% 3.82% Carlyle Secured Lending 14.26% 8.85% 3.90%

Question 13

Which has more risk & volatility, CCAP or CGBD?

Accepted Answer

Crescent Capital BDC has a beta of 0.52, meaning that its share price is 48% less volatile than the broader market. Comparatively, Carlyle Secured Lending has a beta of 0.62, meaning that its share price is 38% less volatile than the broader market.

Question 14

Does the media favor CCAP or CGBD?

Accepted Answer

In the previous week, Crescent Capital BDC had 9 more articles in the media than Carlyle Secured Lending. MarketBeat recorded 10 mentions for Crescent Capital BDC and 1 mentions for Carlyle Secured Lending. Carlyle Secured Lending's average media sentiment score of 1.90 beat Crescent Capital BDC's score of 1.18 indicating that Carlyle Secured Lending is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Crescent Capital BDC 5 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Carlyle Secured Lending 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Question 15

Do analysts rate MFIC or CCAP?

Accepted Answer

MidCap Financial Investment currently has a consensus target price of $11.11, suggesting a potential upside of 13.80%. Crescent Capital BDC has a consensus target price of $13.10, suggesting a potential upside of 22.32%. Given Crescent Capital BDC's stronger consensus rating and higher possible upside, analysts plainly believe Crescent Capital BDC is more favorable than MidCap Financial Investment. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MidCap Financial Investment 1 Sell rating(s) 6 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.11 Crescent Capital BDC 0 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.17

Question 16

Is MFIC or CCAP a better dividend stock?

Accepted Answer

MidCap Financial Investment pays an annual dividend of $1.24 per share and has a dividend yield of 12.7%. Crescent Capital BDC pays an annual dividend of $1.36 per share and has a dividend yield of 12.7%. MidCap Financial Investment pays out -344.4% of its earnings in the form of a dividend. Crescent Capital BDC pays out -1,511.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Crescent Capital BDC has increased its dividend for 1 consecutive years.

Question 17

Which has better valuation & earnings, MFIC or CCAP?

Accepted Answer

MidCap Financial Investment has higher revenue and earnings than Crescent Capital BDC. Crescent Capital BDC is trading at a lower price-to-earnings ratio than MidCap Financial Investment, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio MidCap Financial Investment $320.88M 2.51 $63.17M -$0.36 N/A Crescent Capital BDC $167.29M 2.36 $34.51M -$0.09 N/A

Question 18

Do institutionals and insiders believe in MFIC or CCAP?

Accepted Answer

28.5% of MidCap Financial Investment shares are held by institutional investors. Comparatively, 49.5% of Crescent Capital BDC shares are held by institutional investors. 0.9% of MidCap Financial Investment shares are held by company insiders. Comparatively, 1.2% of Crescent Capital BDC shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Question 19

Is MFIC or CCAP more profitable?

Accepted Answer

Crescent Capital BDC has a net margin of -2.02% compared to MidCap Financial Investment's net margin of -9.85%. MidCap Financial Investment's return on equity of 11.17% beat Crescent Capital BDC's return on equity. Company Net Margins Return on Equity Return on Assets MidCap Financial Investment -9.85% 11.17% 4.41% Crescent Capital BDC -2.02% 9.02% 3.82%

Question 20

Which has more risk and volatility, MFIC or CCAP?

Accepted Answer

MidCap Financial Investment has a beta of 0.61, suggesting that its stock price is 39% less volatile than the broader market. Comparatively, Crescent Capital BDC has a beta of 0.52, suggesting that its stock price is 48% less volatile than the broader market.

Question 21

Does the media refer more to MFIC or CCAP?

Accepted Answer

In the previous week, Crescent Capital BDC had 9 more articles in the media than MidCap Financial Investment. MarketBeat recorded 10 mentions for Crescent Capital BDC and 1 mentions for MidCap Financial Investment. Crescent Capital BDC's average media sentiment score of 1.18 beat MidCap Financial Investment's score of 0.00 indicating that Crescent Capital BDC is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MidCap Financial Investment 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Crescent Capital BDC 5 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Question 22

Do analysts recommend CCAP or SLRC?

Accepted Answer

Crescent Capital BDC currently has a consensus price target of $13.10, suggesting a potential upside of 22.32%. SLR Investment has a consensus price target of $14.10, suggesting a potential upside of 11.64%. Given Crescent Capital BDC's stronger consensus rating and higher probable upside, equities analysts clearly believe Crescent Capital BDC is more favorable than SLR Investment. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Crescent Capital BDC 0 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.17 SLR Investment 2 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.00

Question 23

Is CCAP or SLRC a better dividend stock?

Accepted Answer

Crescent Capital BDC pays an annual dividend of $1.36 per share and has a dividend yield of 12.7%. SLR Investment pays an annual dividend of $1.24 per share and has a dividend yield of 9.8%. Crescent Capital BDC pays out -1,511.1% of its earnings in the form of a dividend. SLR Investment pays out 91.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has increased its dividend for 1 consecutive years. Crescent Capital BDC is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Question 24

Which has better earnings and valuation, CCAP or SLRC?

Accepted Answer

SLR Investment has higher revenue and earnings than Crescent Capital BDC. Crescent Capital BDC is trading at a lower price-to-earnings ratio than SLR Investment, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Crescent Capital BDC $167.29M 2.36 $34.51M -$0.09 N/A SLR Investment $218.54M 3.15 $92.54M $1.35 9.36

Question 25

Do institutionals & insiders hold more shares of CCAP or SLRC?

Accepted Answer

49.5% of Crescent Capital BDC shares are held by institutional investors. Comparatively, 35.3% of SLR Investment shares are held by institutional investors. 1.2% of Crescent Capital BDC shares are held by company insiders. Comparatively, 8.8% of SLR Investment shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Question 26

Is CCAP or SLRC more profitable?

Accepted Answer

SLR Investment has a net margin of 35.20% compared to Crescent Capital BDC's net margin of -2.02%. Crescent Capital BDC's return on equity of 9.02% beat SLR Investment's return on equity. Company Net Margins Return on Equity Return on Assets Crescent Capital BDC -2.02% 9.02% 3.82% SLR Investment 35.20% 7.96% 3.09%

Question 27

Which has more volatility and risk, CCAP or SLRC?

Accepted Answer

Crescent Capital BDC has a beta of 0.52, indicating that its stock price is 48% less volatile than the broader market. Comparatively, SLR Investment has a beta of 0.64, indicating that its stock price is 36% less volatile than the broader market.

Question 28

Does the media refer more to CCAP or SLRC?

Accepted Answer

In the previous week, Crescent Capital BDC had 8 more articles in the media than SLR Investment. MarketBeat recorded 10 mentions for Crescent Capital BDC and 2 mentions for SLR Investment. SLR Investment's average media sentiment score of 1.46 beat Crescent Capital BDC's score of 1.18 indicating that SLR Investment is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Crescent Capital BDC 5 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SLR Investment 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Question 29

Do analysts prefer BCSF or CCAP?

Accepted Answer

Bain Capital Specialty Finance presently has a consensus target price of $12.75, indicating a potential upside of 5.37%. Crescent Capital BDC has a consensus target price of $13.10, indicating a potential upside of 22.32%. Given Crescent Capital BDC's stronger consensus rating and higher probable upside, analysts plainly believe Crescent Capital BDC is more favorable than Bain Capital Specialty Finance. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bain Capital Specialty Finance 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67 Crescent Capital BDC 0 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.17

Question 30

Is BCSF or CCAP a better dividend stock?

Accepted Answer

Bain Capital Specialty Finance pays an annual dividend of $1.68 per share and has a dividend yield of 13.9%. Crescent Capital BDC pays an annual dividend of $1.36 per share and has a dividend yield of 12.7%. Bain Capital Specialty Finance pays out 169.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC pays out -1,511.1% of its earnings in the form of a dividend. Bain Capital Specialty Finance has increased its dividend for 4 consecutive years and Crescent Capital BDC has increased its dividend for 1 consecutive years. Bain Capital Specialty Finance is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Question 31

Which has preferable valuation and earnings, BCSF or CCAP?

Accepted Answer

Bain Capital Specialty Finance has higher revenue and earnings than Crescent Capital BDC. Crescent Capital BDC is trading at a lower price-to-earnings ratio than Bain Capital Specialty Finance, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bain Capital Specialty Finance $273.24M 2.87 $98.76M $0.99 12.22 Crescent Capital BDC $167.29M 2.36 $34.51M -$0.09 N/A

Question 32

Do insiders and institutionals have more ownership in BCSF or CCAP?

Accepted Answer

49.5% of Crescent Capital BDC shares are owned by institutional investors. 0.6% of Bain Capital Specialty Finance shares are owned by insiders. Comparatively, 1.2% of Crescent Capital BDC shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Question 33

Is BCSF or CCAP more profitable?

Accepted Answer

Bain Capital Specialty Finance has a net margin of 24.22% compared to Crescent Capital BDC's net margin of -2.02%. Bain Capital Specialty Finance's return on equity of 10.40% beat Crescent Capital BDC's return on equity. Company Net Margins Return on Equity Return on Assets Bain Capital Specialty Finance 24.22% 10.40% 4.33% Crescent Capital BDC -2.02% 9.02% 3.82%

Question 34

Which has more volatility and risk, BCSF or CCAP?

Accepted Answer

Bain Capital Specialty Finance has a beta of 0.58, suggesting that its stock price is 42% less volatile than the broader market. Comparatively, Crescent Capital BDC has a beta of 0.52, suggesting that its stock price is 48% less volatile than the broader market.

Question 35

Does the media refer more to BCSF or CCAP?

Accepted Answer

In the previous week, Crescent Capital BDC had 8 more articles in the media than Bain Capital Specialty Finance. MarketBeat recorded 10 mentions for Crescent Capital BDC and 2 mentions for Bain Capital Specialty Finance. Crescent Capital BDC's average media sentiment score of 1.18 beat Bain Capital Specialty Finance's score of 0.43 indicating that Crescent Capital BDC is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bain Capital Specialty Finance 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Crescent Capital BDC 5 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Metric	Crescent Capital BDC	Capital Markets Industry	Finance Sector	NASDAQ Exchange
Market Cap	$394.62M	$5.66B	$13.63B	$12.85B
Dividend Yield	12.70%	7.38%	5.89%	10.78%
P/E Ratio	-119.00	39.10	29.61	24.25
Price / Sales	2.36	1,262.42	521.30	100.86
Price / Cash	6.24	48.31	38.19	53.99
Price / Book	0.60	2.13	2.18	6.20
Net Income	$34.51M	$416.48M	$1.31B	$348.59M
7 Day Performance	-3.95%	-0.25%	-0.30%	0.08%
1 Month Performance	-0.65%	2.06%	2.37%	3.88%
1 Year Performance	-29.91%	5.71%	9.68%	16.98%

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CCAP Crescent Capital BDC	4.3455 of 5 stars	$10.71 +0.3%	$13.10 +22.3%	-29.9%	$394.62M	$167.29M	N/A	N/A	News Coverage Positive News
ARCC Ares Capital	3.2194 of 5 stars	$19.67 +0.2%	$20.40 +3.7%	-10.8%	$14.12B	$1.17B	14.57	2,550
CGBD Carlyle Secured Lending	2.3 of 5 stars	$11.21 -0.4%	$12.50 +11.5%	-18.9%	$771.30M	$48.71M	21.98	N/A	Positive News
MFIC MidCap Financial Investment	2.1029 of 5 stars	$9.66 -0.4%	$11.11 +15.0%	-25.7%	$795.69M	$320.88M	N/A	N/A
SLRC SLR Investment	3.9227 of 5 stars	$12.65 -0.2%	$14.10 +11.5%	-23.1%	$690.18M	$218.54M	9.37	N/A	Positive News

Crescent Capital BDC (CCAP) Competitors

CCAP vs. ARCC, CGBD, MFIC, SLRC, and BCSF

How does Crescent Capital BDC compare to Ares Capital?

Summary

How does Crescent Capital BDC compare to Carlyle Secured Lending?

Summary

How does Crescent Capital BDC compare to MidCap Financial Investment?

Summary

How does Crescent Capital BDC compare to SLR Investment?

Summary

How does Crescent Capital BDC compare to Bain Capital Specialty Finance?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCAP vs. The Competition

Crescent Capital BDC Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Crescent Capital BDC (CCAP) Competitors

CCAP vs. ARCC, CGBD, MFIC, SLRC, and BCSF

How does Crescent Capital BDC compare to Ares Capital?

Is ARCC or CCAP more profitable?

Which has higher earnings & valuation, ARCC or CCAP?

Do insiders & institutionals have more ownership in ARCC or CCAP?

Is ARCC or CCAP a better dividend stock?

Do analysts rate ARCC or CCAP?

Does the media prefer ARCC or CCAP?

Which has more risk and volatility, ARCC or CCAP?

Summary

How does Crescent Capital BDC compare to Carlyle Secured Lending?

Do analysts rate CCAP or CGBD?

Is CCAP or CGBD more profitable?

Do insiders and institutionals have more ownership in CCAP or CGBD?

Which has better earnings & valuation, CCAP or CGBD?

Does the media favor CCAP or CGBD?

Which has more risk & volatility, CCAP or CGBD?

Is CCAP or CGBD a better dividend stock?

Summary

How does Crescent Capital BDC compare to MidCap Financial Investment?

Do analysts rate MFIC or CCAP?

Do institutionals and insiders believe in MFIC or CCAP?

Which has more risk and volatility, MFIC or CCAP?

Which has better valuation & earnings, MFIC or CCAP?

Is MFIC or CCAP more profitable?

Is MFIC or CCAP a better dividend stock?

Does the media refer more to MFIC or CCAP?

Summary

How does Crescent Capital BDC compare to SLR Investment?

Which has more volatility and risk, CCAP or SLRC?

Is CCAP or SLRC more profitable?

Do institutionals & insiders hold more shares of CCAP or SLRC?

Does the media refer more to CCAP or SLRC?

Which has better earnings and valuation, CCAP or SLRC?

Do analysts recommend CCAP or SLRC?

Is CCAP or SLRC a better dividend stock?

Summary

How does Crescent Capital BDC compare to Bain Capital Specialty Finance?

Which has preferable valuation and earnings, BCSF or CCAP?

Do insiders and institutionals have more ownership in BCSF or CCAP?

Is BCSF or CCAP more profitable?

Do analysts prefer BCSF or CCAP?

Is BCSF or CCAP a better dividend stock?

Which has more volatility and risk, BCSF or CCAP?

Does the media refer more to BCSF or CCAP?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCAP vs. The Competition

Crescent Capital BDC Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools